Clinical Trials in Michigan

Showing 7041-7060 of 16,154 trials

Study of ASN003 in Subjects With Advanced Solid Tumors

NCT02961283

The study is divided into two parts. The first part of the study will test various doses of ASN003 to find out the highest safe dose to test in three specific groups. The second part of the study will test how well ASN003 can control cancer. Subjects will be enrolled into one of three groups. Group 1: metastatic or recurrent melanoma with documented BRAFV600 mutation (n=20 evaluable patients) Group 2: metastatic colorectal cancer (CRC), or advanced non-small cell lung cancer (NSCLC) with documented BRAFV600 mutation (n=14 evaluable patients) Group 3: advanced solid tumors with documented PI3K pathway alterations (PIK3CA mutation or PTEN loss) (n=14 evaluable patients)

NeoplasmsMelanomaColorectal Neoplasm+1 more

Asana BioSciences24 participantsStarted Oct 2016

Los Angeles, California, United States • Tampa, Florida, United States • Boston, Massachusetts, United States +2 more locations

TERMINATEDPhase 375 miles

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

NCT04745351

The primary objective of this study is to evaluate whether remdesivir (RDV, GS-5734™) reduces the composite risk of death or invasive mechanical ventilation (IMV) through Day 29 in participants with severely reduced kidney function who are hospitalized for coronavirus disease 2019 (COVID-19).

COVID-19

Gilead Sciences249 participantsStarted Mar 2021

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +60 more locations

Study of ASN003 in Subjects With Advanced Solid Tumors

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

Find Trials by Condition in Michigan

First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

A 6 Month Safety Extension Study of MBGS205

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms

Tele-BARICARE to Manage COVID-19-Related Distress

HBV-HIV Coinfection Research Network

P3 Long Term Safety Study of Once Daily SB204 in Acne

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

Fiber to Reduce Colon Cancer in Alaska Native People

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy